StephenJosephBagleyMDMSCE

Neuro-Oncology

Physician

Dr. Bagley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Civic Center Blvd
# Perelman
Philadelphia, PA 19104
Phone+1 215-662-4000

Fax+1 215-615-3704

Stephen J. Bagley, MD, MSCE, is an Assistant Professor of Medicine and Neurosurgery and Section Chief of Neuro-Oncology at the University of Pennsylvania Perelman School of Medicine. As a clinician-scientist, Dr. Bagley focuses both his research and clinical efforts on patients with primary brain and spinal cord tumors. He has particular expertise in translational immunotherapy trials for gliomas, as well as an interest in using blood and cerebrospinal fluid for less invasive molecular characterization and monitoring of brain tumors. Dr. Bagley has led retrospective studies, single institution prospective clinical trials, and multicenter prospective trials conducted nationally through the National Cancer Institute sponsored National Clinical Trials Network. In addition, he has chaired numerous Neuro-Oncology committees and workshops with international scope through the Society for Neuro-Oncology (SNO) and the American Society for Clinical Oncology (ASCO). Dr. Bagley earned his MD and MSCE degrees from Penn and completed both his internal medicine residency and hematology/oncology fellowship at the Hospital of the University of Pennsylvania.

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2014 - 2017
University of Pennsylvania Health SystemResidency, Internal Medicine, 2011 - 2014
Perelman School of Medicine at the University of PennsylvaniaClass of 2011

PubMed

Journal Articles

Thoracic Imaging of Non-Small Cell Lung Cancer Treated with Anti-Programmed Death Receptor-1 Therapy
Sharyn I Katz, Arun C Nachiappan, Joshua Bauml, Stephen Bagley, Charu Aggarwal, Corey Langer, ScienceDirect
Perioperative Beta-blocker and Statin use in Patients with Coronary Artery Disease Undergoing Orthotopic Liver Transplantation
Bagley S, Grzybowski M, Litwack A, and Lilly S, Journal of Clinical Trials in Cardiology, 8/1/2014

Lectures

Impact of antibiotics (ABX) on overall survival (OS) in patients (pts) with advanced non-small-cell lung cancer (aNSCLC) and melanoma (aMel) treated with first-line im...
2019 ASCO Annual Meeting - 6/1/2019
Comparative effectiveness of carboplatin-pemetrexed (Carbo-Pem) with vs. without bevacizumab (Bev) in patients with advanced non-squamous (Sq) non-small cell lung canc...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Thinking Out of the Box: Novel Therapeutic Approaches
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Plasma cell-free DNA (cfDNA) concentration and radiographic tumor burden in patents with glioblastoma (GBM).
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Join now to see all

What Is Glioblastoma and What Are the Main Symptoms to Look Out For?August 31st, 2022
Brain Imaging Predicts Benefit of Liquid Biopsy in GlioblastomaMarch 5th, 2020
Imaging Can Guide Whether Liquid Biopsy Will Benefit Individual Glioblastoma Patients: Study Shows MRI May Help Identify Appropriate Liquid Biopsy CandidatesMarch 1st, 2020
Join now to see all